GD1bCer (d18:1/12:0) is a glycosphingolipid and sialic acid-containing substance that can be used in the research of treatments for neurodegenerative diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.